DYN
Price
$25.63
Change
+$1.19 (+4.87%)
Updated
Jul 27 closing price
Capitalization
4.24B
2 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$10.15
Change
-$0.24 (-2.31%)
Updated
Jul 27 closing price
Capitalization
901.5M
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs KURA

DYN vs KURA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DYN vs. KURA commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and KURA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2026
Stock price -- (DYN: $25.63 vs. KURA: $10.15)
Brand notoriety: DYN and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 90% vs. KURA: 49%
Market capitalization -- DYN: $4.24B vs. KURA: $901.5M
DYN [@Biotechnology] is valued at $4.24B. KURA’s [@Biotechnology] market capitalization is $901.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 0 FA rating(s) are green whileKURA’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 5 TA indicator(s) are bullish while KURA’s TA Score has 5 bullish TA indicator(s).

  • DYN’s TA Score: 5 bullish, 4 bearish.
  • KURA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DYN is a better buy in the short-term than KURA.

Price Growth

DYN (@Biotechnology) experienced а +9.30% price change this week, while KURA (@Biotechnology) price change was -4.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.94%. For the same industry, the average monthly price growth was -4.26%, and the average quarterly price growth was +1936.60%.

Reported Earning Dates

DYN is expected to report earnings on Jul 30, 2026.

KURA is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-1.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($4.24B) has a higher market cap than KURA($902M). DYN YTD gains are higher at: 31.033 vs. KURA (-2.310). KURA has higher annual earnings (EBITDA): -291.88M vs. DYN (-439.22M). DYN has more cash in the bank: 972M vs. KURA (581M). KURA has less debt than DYN: KURA (24.3M) vs DYN (169M). KURA has higher revenues than DYN: KURA (71.6M) vs DYN (0).
DYNKURADYN / KURA
Capitalization4.24B902M470%
EBITDA-439.22M-291.88M150%
Gain YTD31.033-2.310-1,343%
P/E RatioN/AN/A-
Revenue071.6M-
Total Cash972M581M167%
Total Debt169M24.3M695%
FUNDAMENTALS RATINGS
DYN vs KURA: Fundamental Ratings
DYN
KURA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3542
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DYN's Valuation (37) in the Electric Utilities industry is in the same range as KURA (52) in the Biotechnology industry. This means that DYN’s stock grew similarly to KURA’s over the last 12 months.

DYN's Profit vs Risk Rating (94) in the Electric Utilities industry is in the same range as KURA (100) in the Biotechnology industry. This means that DYN’s stock grew similarly to KURA’s over the last 12 months.

DYN's SMR Rating (99) in the Electric Utilities industry is in the same range as KURA (99) in the Biotechnology industry. This means that DYN’s stock grew similarly to KURA’s over the last 12 months.

DYN's Price Growth Rating (35) in the Electric Utilities industry is in the same range as KURA (42) in the Biotechnology industry. This means that DYN’s stock grew similarly to KURA’s over the last 12 months.

DYN's P/E Growth Rating (100) in the Electric Utilities industry is in the same range as KURA (100) in the Biotechnology industry. This means that DYN’s stock grew similarly to KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DYNKURA
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GBTC50.280.56
+1.13%
Grayscale Bitcoin Trust ETF
TCV32.770.21
+0.64%
Towle Value ETF
OWNS17.100.06
+0.35%
CCM Affordable Housing MBS ETF
SGDM62.470.16
+0.26%
Sprott Gold Miners ETF
KCSH25.10N/A
N/A
Kraneshares Sust Ultra Shrt Dur Idx ETF

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+4.87%
RNA - DYN
64%
Loosely correlated
+0.70%
RCUS - DYN
46%
Loosely correlated
-2.04%
NTLA - DYN
44%
Loosely correlated
-0.56%
VYGR - DYN
44%
Loosely correlated
-0.32%
SLDB - DYN
43%
Loosely correlated
+0.77%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with IMVT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-2.31%
IMVT - KURA
52%
Loosely correlated
+1.73%
VYGR - KURA
51%
Loosely correlated
-0.32%
CLDX - KURA
50%
Loosely correlated
+1.05%
RLAY - KURA
49%
Loosely correlated
+1.08%
IMNM - KURA
49%
Loosely correlated
+1.67%
More